Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.30 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL197104 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL8613098 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL8615317 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL8613264 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL197971 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL6258951 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL8090318 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL8614288 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL345851 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL8613060 | 1.00 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021044-A1 | POROUS HYDROGEL MICROSPHERES AND PREPARATION METHODS THEREOF | SICHUAN CELL TISSUE BANK ENGINEERING TECHNOLOGY CO., LTD. (CN) | 2026-01-22 | — | — | US | claimed |
| US-20260021044-A1 | POROUS HYDROGEL MICROSPHERES AND PREPARATION METHODS THEREOF | SICHUAN CELL TISSUE BANK ENGINEERING TECHNOLOGY CO., LTD. (CN) | 2026-01-22 | — | — | US | disclosed |
| US-6825377-B1 | CATALYTIC OXIDATION USING OXYGEN OR GAS MIXTURE IN PRESENCE OF OSMIUM, RUTHENIUM, OR MANGANESE COMPOUND IN WATER; ADDING AMINE FOR CATALYST SELECTIVITY | BAYER AKTIENGESELLSCHAFT (DE) | 2004-11-30 | — | — | US | disclosed |
| US-6472570-B1 | Method for the asymmetric dihydroxylation of olefins, using osmium catalysts | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-29 | — | — | US | disclosed |
| EP-0837085-A1 | POLYCARBONATE-BASE POLYMER, PRODUCTION PROCESS, RESIN COATING FLUID PREPARED THEREFROM, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR PREPARED THEREFROM | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1998-04-22 | — | — | EP | disclosed |
| EP-0540976-A1 | Use of polyisocyanate solutions for the impregnation of mineral substrates | BAYER AG (DE) | 1993-05-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021044-A1 | POROUS HYDROGEL MICROSPHERES AND PREPARATION METHODS THEREOF | MKI67, PCNA, STUB1 | LMNA 253/4885THRB 3967/4885CA2 4453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.